[CAPR] QoQ Quarter Result on 31-Dec-2023 [#Q4]

Stock
[CAPR] Capricor Therapeutics, Inc.
Announcement Date
11-Mar-2024
Financial Year
2023
Quarter
31-Dec-2023 [#Q4]
Profit Trend
QoQ- 88.08%
YoY- 90.26%
Quarter Report
CAPR's Result
CAPR's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
Revenue 2,261,642 3,971 4,907 12,088 6,186 3,917 2,987 8107.57%
PBT -12,556,728 -11,000 -9,794 -762 -6,391 -7,367 -7,768 13489.40%
Tax -12,556,728 0 0 0 -276 -503 -416,442 862.76%
NP -12,556,728 -11,000 -9,794 -762 -6,391 -7,367 408,674 -
Tax Rate - - - - - - - -
Total Cost 14,818,370 14,971 14,701 12,850 12,576 11,284 -405,687 -
Ratio Analysis
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
NP Margin -555.20 -276.97 -199.60 -6.30 -103.31 -188.04 13,683.14 -
Per Share
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
EPS -379.47 -0.35 -0.31 -0.02 -0.25 -0.29 16.19 -
EPS Diluted -379.47 -0.35 -0.31 -0.02 -0.25 -0.29 16.19 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.